Marksans Pharma Limited has informed the Exchange regarding a press release dated February 25, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK Relonchem Limited, receives Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets".